Retatrutide vs Semaglutide: Quick Comparison: Retatrutide vs Semaglutide Semaglutide Retatrutide Receptor targets GLP-1 (single agonist) GLP-1, GIP, glucagon (triple agonist) Developer Novo Nordisk Eli Lilly Regulatory status FDA/MHRA approved Phase 3, not approved anywhere Brand names Ozempic, Wegovy, Rybelsus None (investigational) Peak trial weight loss ~14.9%–20.7% (STEP 1 / STEP UP) 28.3%–30.3% (TRIUMPH-1) Administration […]
